World Health Organization, 2000. Expert Committee on Malaria. Twentieth Report. World Health Organ Techn Rep Ser 892.
McGregor IA, 1984. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 33 :517–525.
Brabin BJ, 1983. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 61 :1005–1016.
Vleugels MP, Eling WM, Rolland R, de Graff R, 1986. Cortisol levels in human pregnancy in relation to parity and age. Am J Obstet Gynecol 155 :118–121.
Weinberg ED, 1984. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 6 :814–831.
Riley EM, Schneider G, Sambou I, Greenwood BM, 1989. Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. Am J Trop Med Hyg 40 :141–144.
Fievet N, Cot M, Chougnet C, Maubert B, Bickii J, Dubois B, Le Hesran JY, Frobert Y, Migot F, Romain F, Verhave JP, Louis FA, Deloron P, 1995. Malaria and pregnancy in Cameroonian primigravidae: humoral and cellular immune responses to Plasmodium falciparum blood-stage antigens. Am J Trop Med Hyg 53 :612–617.
Moore JM, Nahlen BL, Misore A, Lal AA, Udhayakumar V, 1999. Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria. J Infect Dis 179 :1218–1225.
Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE, 1988. Maternal antibodies block malaria. Nature 395 :851–852.
Pasvol G, Weatherall DJ, Wilson RJ, Smith DH, Gilles HM, 1976. Fetal haemoglobin and malaria. Lancet 1 :1269–1272.
Gilbertson M, Fletcher KA, Maegraith BG, 1969. Host-diet-parasite relationships in Plasmodium berghei malaria in mice. Trans R Soc Trop Med Hyg 63 :7–10.
Mcfarlane H, Voller A, 1966. Studies on immunoglobulins of Nigerians. II. Immunoglobulins and malaria infection in Nigerians. J Trop Med Hyg 69 :104–107.
Sehgal VM, Siddjiqui WA, Alpers MP, 1989. A seroepidemio-logical study to evaluate the role of passive maternal immunity to malaria in infants. Trans R Soc Trop Med Hyg 83 (Suppl):105–106.
Robb A, 1999. Malaria and pregnancy: the implementation of interventions. Ann Trop Med Parasitol 93 (Suppl 1):S67–S70.
Gimnig JE, Vulule JM, Lo TQ, Kamau L, Kolczak MS, Phillips-Howard PA, Mathenge EM, ter Kuile FO, Nahlen BL, High-tower AW, Hawley WA, 2003. Impact of permethrin-treated bed nets on entomologic indices in an area of intense year-round malaria transmission. Am J Trop Med Hyg 68 (Suppl 4):16–22.
ter Kuile FO, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kariuki SK, Shi YP, Kolczak MS, Lal AA, Vulule JM, Nahlen BL, 2003. Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg 68 (Suppl 4):50–60.
Genton B, Hii J, al-Yaman F, Paru R, Beck HP, Ginny M, Dagoro H, Lewis D, Alpers MP, 1994. The use of untreated bednets and malaria infection, morbidity and immunity. Ann Trop Med Parasitol 88 :263–270.
Snow RW, Molyneux CS, Warn PA, Omumbo J, Nevill CG, Gupta S, Marsh K, 1996. Infant parasite rates and immunoglobulin M seroprevalence as a measure of exposure to Plasmodium falciparum during a randomized controlled trial of insecticide-treated bed nets on the Kenyan coast. Am J Trop Med Hyg 55 :144–149.
Askjaer N, Maxwell C, Chambo W, Staalsoe T, Nielsen M, Hviid L, Curtis C, Theander TG, 2001. Insecticide-treated bed nets reduce plasma antibody levels and limit the repertoire of antibodies to Plasmodium falciparum variant surface antigens. Clin Diagn Lab Immunol 8 :1289–1291.
Kariuki SK, Lal AA, Terlouw DJ, ter Kuile FO, Ong’echa JMO, Phillips-Howard PA, Orago ASS, Kolczak MS, Hawley WA, Nahlen BL, Shi YP, 2003. Effects of permethrin-treated bed nets on immunity to malaria in western Kenya. II: Antibody responses in young children in an area of intense malaria transmission. Am J Trop Med Hyg 68 (Suppl 4):108–114.
Fidock DA, Gras-Masse H, Lepers JP, Brahimi K, Benmohamed L, Mellouk S, Guerin-Marchand C, Londono A, Raharimalala L, Meiss JFGM, Lanngsley G, Roussilhon C, Tartar A, Druilhe P, 1994. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol 153 :190–204.
Rogier C, Trape JF, 1993. Malaria attacks in children exposed to high transmission: who is protected? Trans R Soc Trop Med Hyg 87 :245–246.
Bloland PB, Boriga DA, Ruebush TK, McCormick JM, Roberts JM, Oloo AJ, Hawley W, Lal A, Nahlen B, Campbell CC, 1999. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and diseases among children. Am J Trop Med Hyg 60 :641–648.
Greenwood B, 1996. What can be expected from malaria vaccines? Hoffman SL, ed. Malaria Vaccine Development: A Multi-Immune Approach. Washington, DC: American Society for Microbiology Press, 277–301.
Playfair JH, Taverne J, Bate CA, de Souza JB, 1990. The malaria vaccine: anti-parasite or anti-disease? Immunol Today 11 :25–27.
Sokhna CS, Rogier C, Dieye A, Trape JF, 2000. Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission. Am J Trop Med Hyg 62 :266–270.
Orjih AU, Nussenzweig RS, 1979. Plasmodium berghei: suppression of antibody response to sporozoite stage by acute blood stage infection. Clin Exp Immunol 38 :1–8.
Nardin EH, Nussenzweig RS, McGregor IA, Bryan JH, 1979. Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science 206 :597–599.
Daniel-Ribeiro C, de Oliveira-Ferreira J, Banic DM, Galvao-Castro B, 1989. Can malaria-associated polyclonal B-lymphocyte activation interfere with the development of anti-sporozoite specific immunity? Trans R Soc Trop Med Hyg 83 :289–292.
Branch OH, Udhayakumar V, Hightower AW, Oloo AJ, Hawley WA, Nahlen BL, Bloland PB, Kaslow DC, Lal AA, 1998. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg. 58 :211–219.
Shi YP, Sayed U, Qari SH, Roberts JM, Udhayakumar V, Oloo AJ, Hawley WA, Kaslow DC, Nahlen BL, Lal AA, 1996. Natural immune responses to the C-terminal 19-kilodaltons domain of Plasmodium falciparum merozoite surface protein-1. Infect Immun 64 :2716–2723.
Deloron P, Dubois B, Le Hesran JY, Riche D, Fievet N, Cornet M, Ringwald P, Cot M, 1997. Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp Immunol 110 :212–218.
Riley EM, Wagner GE, Ofori MF, Wheeler JG, Akanmori BD, Tetteh K, McGuinness D, Bennett S, Nkrumah FK, Anders RF, Koram KA, 2000. Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun 68 :5856–5863.
Hogh B, Marbiah NT, Burghaus PA, Andersen PK, 1995. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic. Infect Immun 63 :4034–4038.
ter Kuile FO, Terlouw DJ, Kariuki SK, Phillips-Howard PA, Mirel LB, Hawley WA, Friedman JF, Shi YP, Kolczak MS, Lal AA, Vulule JM, Nahlen BL, 2003. Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg 68 (Suppl 4):68–77.
|Past two years||Past Year||Past 30 Days|
|Full Text Views||532||230||1|
As part of a community-based group-randomized trial on the impact of permethrin-treated bed nets (ITNs) on malaria in pregnancy in a holoendemic area of western Kenya, we assessed their effects on antibody responses to Plasmodium falciparum pre-erythrocytic antigens (recombinant circumsporozoite protein [CSP] and peptides complimentary to the repeat region of the liver stage antigen-1 [LSA-1]) and blood stage antigen (recombinant C-terminal domain of the merozoite surface protein-1 [MSP-119 kD]) in paired maternal/cord plasma samples obtained from 296 deliveries (157 from ITN villages and 139 control villages). Levels of total IgG and IgG subclasses 1–3 to LSA-1 and total IgG and IgG3 to MSP-1 were lower, whereas those of total IgG to CSP were significantly higher in women from ITN villages than those from control villages. In cord plasma, levels of total IgG and IgG2 to LSA-1 and IgG3 to MSP-1 were lower in ITN villages than in control villages, but antibody responses to CSP were similar. Our results suggest that the use of ITNs decreases antibody responses to LSA-1 and MSP-1 antigens in pregnant women with associated reductions in levels of the same antibodies in cord blood. In contrast, ITN use was found to be associated with increased antibody responses to CSP in pregnant women, but had no effect on antibody levels to CSP in cord blood.